Skip to Content

Join the 'Bacterial Vaginitis' group to help and get support from people like you.

Bacterial Vaginitis News

Related terms: Bacterial Vaginoses, Bacterial Vaginosis

Vitamin D May Not Prevent Return of Women's Infection After All

Posted 28 Oct 2014 by Drugs.com

TUESDAY, Oct. 28, 2014 – A new study suggests that high doses of vitamin D may not help prevent the return of vaginosis, a vaginal infection that's especially common in younger women. The findings counter other research that suggests higher vitamin D levels could boost the immune system as it tries to fight off the infection, according to background information in the study. "Earlier studies observed that women with low vitamin D levels were more likely to have bacterial vaginosis, and we hypothesized that vitamin D supplementation might reduce [bacterial vaginosis]," study author Abigail Norris Turner, an infectious disease expert at the Ohio State University Wexner Medical Center, said in a university news release. "However, our study found that high-dose vitamin D supplementation wasn't helpful in preventing recurrence of [bacterial vaginosis]," she said. Vaginosis, which is not ... Read more

Related support groups: Vitamin D, Bacterial Vaginitis, Vitamin D3, D3, Cholecalciferol, Ergocalciferol, Drisdol, Hectorol, Replesta, Doxercalciferol, Delta D3, Calciferol, D3-5, Maximum D3, D400, D2000, D 1000 IU, D3-50, Decara, Calcidol

Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%

Posted 25 Mar 2014 by Drugs.com

DUBLIN and LAVAL, Quebec, March 25, 2014 /PRNewswire/ – Actavis plc (NYSE: ACT) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Metronidazole 1.3% Vaginal Gel, an antibiotic for the treatment of bacterial vaginosis (BV). Actavis acquired the rights to Metronidazole 1.3% from Valeant Pharmaceuticals International in April 2013. Bacterial vaginosis is an infection caused by an imbalance in the normal bacteria in the vagina. It is the most common vaginal infection in women ages 15 to 44[i]. Metronidazole 1.3% provides a convenient, single-dose treatment for BV that is packaged in a pre-filled disposable applicator. The U.S. BV market is valued at approximately $140 million annually, according to IMS Health. "The approval of Metronidazole 1.3% is a ... Read more

Related support groups: Bacterial Vaginitis, MetroGel, MetroGel-Vaginal, Vandazole, MetroLotion, Rozex, MetroCream, Rosadan, Noritate, Vitazol

Petroleum Jelly Tied to Vaginal Infection Risk in Study

Posted 8 Mar 2013 by Drugs.com

FRIDAY, March 8 – Women who use petroleum jelly vaginally may put themselves at risk of a common infection called bacterial vaginosis, a small study suggests. Prior studies have linked douching to ill effects, including bacterial vaginosis, and an increased risk of sexually transmitted diseases and pelvic inflammatory disease. But little research has been conducted on the possible effects of other products some women use vaginally, said Joelle Brown, a researcher at the University of California, San Francisco, who led the new study. She and her colleagues found that of 141 Los Angeles women they studied, half said they'd used some type of over-the-counter product vaginally in the past month, including sexual lubricants, petroleum jelly and baby oil. Almost as many, 45 percent, reported douching. When the researchers tested the women for infections, they found that those who'd used ... Read more

Related support groups: Bacterial Vaginitis, Vaseline, Uni Salve, Probax, Petrolatum, Ilex Skin

Bacterial Vaginosis Increases Female-to-Male HIV Transmission Risk

Posted 26 Jun 2012 by Drugs.com

TUESDAY, June 26 – HIV-positive women with bacterial vaginosis, a disruption in the normal balance between healthy and harmful bacteria in the vagina, are three times more likely to pass HIV on to male sexual partners, according to a new study. Researchers from the University of California-San Francisco, said new developments in treatment for bacterial vaginosis could not only improve women's health, but also help reduce HIV transmission rates. "Previous research has shown that bacterial vaginosis can increase women's risk of becoming infected with HIV by as much as 60 percent," lead study author Dr. Craig Cohen, professor of obstetrics, gynecology and reproductive sciences, said in a university news release. "Our study is the first to show that the risk of transmitting HIV is also elevated." In conducting the study, the researchers examined the link between bacterial vaginosis and ... Read more

Related support groups: HIV Infection, Bacterial Vaginitis

Study Redefines What a Healthy Vagina Is

Posted 2 May 2012 by Drugs.com

WEDNESDAY, May 2 – Bacteria that live normally in the vagina differ from woman to woman and can even change dramatically in short periods of time in the same woman, a new analysis reveals. The findings are likely to alter the one-size-fits-all diagnosis and treatment of vaginal infections that currently prevails among obstetricians and gynecologists. "This certainly changes the diagnosis, treatment and prevention of vaginosis (bacterial infection in the vagina)," said Stephen Dewhurst, chairman of microbiology and immunology at the University of Rochester Medical Center in New York. "Among other things, this makes vaginosis much harder to diagnose. If [vaginal bacteria] change over time, how sure are you that this really is vaginosis?" Dewhurst was not involved with the study, which appears in the May 2 issue of the journal Science Translational Medicine. "In the practice of medicine, ... Read more

Related support groups: Bacterial Vaginitis

Birth Control May Help Ward Off Bacterial Vaginosis

Posted 16 Dec 2009 by Drugs.com

THURSDAY, July 30 – Women who are prone to the common vaginal infection, bacterial vaginosis, are less likely to have a recurrence if they take hormonal contraception, whether it be birth control pills or Depo-Provera injections, new research suggests. In the study, researchers examined medical records for 330 women with a mean age of nearly 25 who visited two sexually transmitted disease clinics in Baltimore between April 2005 and October 2006. About 133, or 40.3 percent, were diagnosed with bacterial vaginosis. The women were prescribed a contraceptive, either progestin only (such as Depo-Provera) or estrogen-progestin combination (a birth control pill). Women who were taking an oral contraceptive that included estrogen and progestin were 34 percent less likely to have a recurrence of bacterial vaginosis than women not taking a contraceptive. Women who were on a progestin-only ... Read more

Related support groups: Birth Control, Contraception, Plan B, Mirena, NuvaRing, Sprintec, Provera, Implanon, Depo-Provera, Ortho Tri-Cyclen, Tri-Sprintec, Yasmin, Microgestin Fe 1/20, Loestrin 24 Fe, Ortho Evra, TriNessa, Lutera, Mononessa, Ortho Tri-Cyclen Lo, Bacterial Vaginitis

Ask a Question

Further Information

Related Condition Support Groups

Bacterial Infection

Related Drug Support Groups

metronidazole, clindamycin, Cleocin, Metro, tinidazole, MetroGel-Vaginal, Vandazole, Tindamax, Cleocin HCl, view more... Cleocin Pediatric, Flagyl ER, Fem pH, Clindesse, Fasigyn, Cleocin Phosphate, Nuvessa, Acidic Vaginal Jelly, Clindacin PAC, Relagard, Pledgaclin, Clindacin P, Feminique, Metryl, Metro IV, Clindamax, Acid Jelly, Protostat, Cleocin Vaginal, Massengill Douche, Aci-Jel, Cleocin Ovules, Bidette